KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Synopsys (SNPS) EBT: 2009-2025

Historic EBT for Synopsys (SNPS) over the last 16 years, with Jul 2025 value amounting to $189.3 million.

  • Synopsys' EBT fell 51.71% to $189.3 million in Q3 2025 from the same period last year, while for Jul 2025 it was $1.2 billion, marking a year-over-year decrease of 24.78%. This contributed to the annual value of $1.5 billion for FY2024, which is 15.96% up from last year.
  • Per Synopsys' latest filing, its EBT stood at $189.3 million for Q3 2025, which was down 52.22% from $396.2 million recorded in Q2 2025.
  • In the past 5 years, Synopsys' EBT registered a high of $457.5 million during Q1 2024, and its lowest value of $177.1 million during Q1 2021.
  • Over the past 3 years, Synopsys' median EBT value was $325.6 million (recorded in 2023), while the average stood at $336.0 million.
  • Per our database at Business Quant, Synopsys' EBT spiked by 101.81% in 2023 and then crashed by 51.71% in 2025.
  • Quarterly analysis of 5 years shows Synopsys' EBT stood at $199.1 million in 2021, then rose by 0.50% to $200.1 million in 2022, then soared by 101.81% to $403.8 million in 2023, then dropped by 20.03% to $322.9 million in 2024, then plummeted by 51.71% to $189.3 million in 2025.
  • Its EBT was $189.3 million in Q3 2025, compared to $396.2 million in Q2 2025 and $291.1 million in Q1 2025.